Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improvement of synaptic plasticity and cognitive function in RAS pathway disorders
2016-005022-10Phase 2Completed
- Sponsor
- Technical University of Munich Faculty of Medicine
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lovastatin and lamotrigine in Noonan syndrome and neurofibromatosis type 1 (NF1) (2 cohorts), sponsored by Technical University of Munich Faculty of Medicine. Started Nov 2017; status: completed.
02
Drugs
lovastatinlamotrigine
03
Conditions
Noonan syndromeneurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on 2016-005022-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005022-10.